We are in the process of enrolling dialysis and kidney transplant patients in our studies on the genetic epidemiology of chronic kidney disease outcomes. We will be evaluating an omnigenic model of chronic kidney disease, including monogenic and polygenic risk scores.
We are currently conducting studies involving patients on hemodialysis, including looking at hemodialysis-related changes in over 1,000 biomarkers.
Precision Medicine for PKD
We are working to advance current understanding of polycystic kidney disease in an effort to move towards a precision medicine approach to treatment.
Evaluating Genomics Study Targets
We are currently looking for genetic evidence for the roles of target proteins, identified through genomics studies, in kidney disease.
CONTACT Dr. Matthew Lanktree email@example.com Twitter: @MattLanktree